Assisted reproductive technology and ovarian cancer

被引:1
|
作者
Devesa, M. [1 ]
Barri, P. N. [1 ]
Coroleu, B. [1 ]
机构
[1] Inst Univ Dexeus, Serv Reprod Med, Dept Obstet Gynecol & Reprod, Barcelona 08028, Spain
关键词
Ovarian neoplasms; Infertility; Fertility agents; Ovulation induction; IN-VITRO FERTILIZATION; ORAL-CONTRACEPTIVE USE; TERM-FOLLOW-UP; FERTILITY DRUGS; OVULATION INDUCTION; INFERTILE WOMEN; RISK; STIMULATION; COHORT; BREAST;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ovarian cancer has the highest mortality among all gynaecological cancers, being multiparity and oral contraceptive use the most important protective factors. According to both the "incessant ovulation" and "increased gonadotrophin" theories, fertility drugs might hive an association with the development of ovarian cancer, as has been reported by some studies. However, infertility and nulliparity may act as confounding factors and most studies regarding this issue are hampered by methodological limitations. It seems that female infertility may be associated with a modest increase in ovarian cancer risk in those patients who remain nulligravid despite long periods of unprotected intercourse. Globally, most studies are reassuring in not showing a link between the use of fertility drugs and an increased risk of ovarian cancer. Nonetheless, further research in well-designed studies is warranted.
引用
收藏
页码:247 / 257
页数:11
相关论文
共 50 条
  • [41] IS ASSISTED REPRODUCTIVE TECHNOLOGY ASSOCIATED WITH INCREASED RISK OF CANCER?
    Williams, E.
    Ratnaraj, D.
    Holme, H.
    PEDIATRIC RESEARCH, 2011, 70 : 360 - 360
  • [42] ASSISTED REPRODUCTIVE TECHNOLOGY & RISK OF CANCER IN WOMEN.
    Luke, B.
    Spector, L. G.
    Brown, M. B.
    Schymura, M. J.
    Missmer, S. A.
    Leach, R. E.
    FERTILITY AND STERILITY, 2013, 100 (03) : S164 - S165
  • [43] Assisted reproductive technology
    Yablonsky, T
    LABORATORY MEDICINE, 1996, 27 (08) : 524 - 531
  • [44] Assisted reproductive technology
    SCIENTIFIC AND MEDICAL ASPECTS OF HUMAN REPRODUCTIVE CLONING, 2002, : 61 - 73
  • [45] ASSISTED REPRODUCTIVE TECHNOLOGY
    BAIRD, P
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1993, 149 (09) : 1225 - 1226
  • [46] ASSISTED REPRODUCTIVE TECHNOLOGY
    TANBO, T
    ABYHOLM, T
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 1991, 3 (05) : 649 - 655
  • [47] ASSISTED REPRODUCTIVE TECHNOLOGY
    SAUER, MV
    WESTERN JOURNAL OF MEDICINE, 1994, 161 (02): : 164 - 165
  • [48] Assisted reproductive technology treatment and risk of ovarian cancer-a nationwide population-based cohort study
    Vassard, D.
    Schmidt, L.
    Glazer, C. H.
    Lyng Forman, J.
    Kamper-Jorgensen, M.
    Pinborg, A.
    HUMAN REPRODUCTION, 2019, 34 (11) : 2290 - 2296
  • [49] Methotrexate does not affect ovarian reserve or subsequent assisted reproductive technology outcomes
    Christina E. Boots
    Micah J. Hill
    Eve C. Feinberg
    Ruth B. Lathi
    Susan A. Fowler
    Emily S. Jungheim
    Journal of Assisted Reproduction and Genetics, 2016, 33 : 647 - 656
  • [50] Long-term risk of ovarian tumours after assisted reproductive technology
    Spaan, M.
    Van den Belt-Dusebout, W.
    Lambalk, C. B.
    Van Boven, H. H.
    Burger, C. W.
    Van Leeuwen, F. E.
    HUMAN REPRODUCTION, 2019, 34 : 79 - 79